Johnson & Johnson Revenues
Johnson & Johnson (JNJ) reported Revenues of $18.47 billion for the 3-month period ending 2014-09-28, per its 10-Q filed 2014-10-30.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2014-10-30
- Johnson & Johnson revenues for the quarter ending 2014-09-28 was $18.47B, a 5.08% increase year-over-year.
- Johnson & Johnson revenues for the quarter ending 2014-06-29 was $19.50B, a 9.05% increase year-over-year.
- Johnson & Johnson revenues for the quarter ending 2014-03-30 was $18.11B, a 3.48% increase year-over-year.
- Johnson & Johnson revenues for the quarter ending 2013-09-29 was $17.57B, a 3.07% increase year-over-year.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month |
|---|---|---|---|
| 2014-09-28 | $18.47B 10-Q · filed 2014-10-30 | $37.96B derived: sum of 2 quarters · filed 2014-10-30 | $56.08B 10-Q · filed 2014-10-30 |
| 2014-06-29 | $19.50B 10-Q · filed 2014-08-01 | $37.61B 10-Q · filed 2014-08-01 | |
| 2014-03-30 | $18.11B 10-Q · filed 2014-05-02 | ||
| 2013-09-29 | $17.57B 10-Q · filed 2014-10-30 | $35.45B derived: sum of 2 quarters · filed 2014-10-30 | $52.96B 10-Q · filed 2014-10-30 |
| 2013-06-30 | $17.88B 10-Q · filed 2014-08-01 | $35.38B 10-Q · filed 2014-08-01 | |
| 2013-03-31 | $17.50B 10-Q · filed 2014-05-02 | ||
| 2012-09-30 | $17.05B 10-Q · filed 2013-11-04 | $33.53B derived: sum of 2 quarters · filed 2013-11-04 | $49.67B 10-Q · filed 2013-11-04 |
| 2012-07-01 | $16.48B 10-Q · filed 2013-08-01 | $32.61B 10-Q · filed 2013-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |